Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The subdermal connective tissue matrix is the network of extracellular proteins and ground substance located beneath the dermis in subcutaneous tissue. Major components include various collagens (primarily types I and III), elastin, glycosaminoglycans (such as hyaluronic acid), and proteoglycans, all secreted and maintained by resident fibroblasts[3][1][6][5]. The matrix provides structural integrity and mechanical strength, regulates fluid balance and nutrient exchange, and plays essential roles in wound healing, immune response modulation, and tissue elasticity[1][4][2][5]. Fibroblasts actively remodel the matrix in response to external mechanical stress, protecting tissues from swelling and mediating physiological processes such as repair, fibrosis, and cancer progression[4][3]. Because the term is anatomical and not a single molecule, it should not be classified as a specific drug target or receptor.
Enzyme inhibitors (e.g., matrix metalloproteinase inhibitors prevent breakdown of ECM) - Anti-fibrotic agents (alter deposition or remodeling of ECM components) - Immunomodulators (affect immune cell function within the matrix)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Subdermal connective tissue matrix.